Results 331 to 340 of about 157,262 (340)
Some of the next articles are maybe not open access.
Exclusive patent and know-how license to make, have made, use, import, offer, sell, research, develop and sublicense products, including a topical gel, that are a combination of the compound resiquimod, which is an IRM (Immune Response Modifier) to toll-like receptor (TLR) 7 and/or 8 used as a vaccine adjuvant, and licensee's APC (Antigen Presenting Cell) technology, for human prophylactic or therapeutic vaccination against cancer, and the infectious diseases HIV, HPV and hepatitis B virus.
2009 openaire +1 more source